- Home
- RAPT vs KELYA Comparison
RAPT vs KELYA Comparison
Compare RAPT & KELYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- KELYA
- Stock Information
- Founded
- RAPT 2015
- KELYA 1946
- Country
- RAPT United States
- KELYA United States
- Employees
- RAPT N/A
- KELYA N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- KELYA Professional Services
- Sector
- RAPT Health Care
- KELYA Consumer Discretionary
- Exchange
- RAPT Nasdaq
- KELYA Nasdaq
- Market Cap
- RAPT 498.4M
- KELYA 438.6M
- IPO Year
- RAPT 2019
- KELYA N/A
- Fundamental
- Price
- RAPT $29.86
- KELYA $12.58
- Analyst Decision
- RAPT Strong Buy
- KELYA Buy
- Analyst Count
- RAPT 8
- KELYA 1
- Target Price
- RAPT $46.75
- KELYA $25.00
- AVG Volume (30 Days)
- RAPT 614.9K
- KELYA 270.7K
- Earning Date
- RAPT 11-11-2025
- KELYA 11-06-2025
- Dividend Yield
- RAPT N/A
- KELYA 2.39%
- EPS Growth
- RAPT N/A
- KELYA N/A
- EPS
- RAPT N/A
- KELYA N/A
- Revenue
- RAPT N/A
- KELYA $4,495,900,000.00
- Revenue This Year
- RAPT N/A
- KELYA $4.55
- Revenue Next Year
- RAPT N/A
- KELYA $5.01
- P/E Ratio
- RAPT N/A
- KELYA N/A
- Revenue Growth
- RAPT N/A
- KELYA 0.97
- 52 Week Low
- RAPT $5.67
- KELYA $10.80
- 52 Week High
- RAPT $42.39
- KELYA $22.44
- Technical
- Relative Strength Index (RSI)
- RAPT 61.81
- KELYA 42.61
- Support Level
- RAPT $25.50
- KELYA $12.13
- Resistance Level
- RAPT $42.39
- KELYA $12.59
- Average True Range (ATR)
- RAPT 3.91
- KELYA 0.31
- MACD
- RAPT -0.18
- KELYA 0.01
- Stochastic Oscillator
- RAPT 30.92
- KELYA 40.83
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About KELYA Kelly Services Inc.
Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.